Erythropoietin: its biological properties and clinical use
Ermolenko, V.M.; Nikolaev, A.I.
Terapevticheskii Arkhiv 62(11): 141-145
1990
ISSN/ISBN: 0040-3660 PMID: 2094979 Document Number: 358624
Document emailed within 1 workday
Related Documents
Liberato, N.L.; Costa, A.; Barosi, G. 1990: Erythropoietin: biological aspects and clinical usefulness Haematologica 75(4): 346-362Lebel-Binay, S.; Berger, A.; Zinzindohoué, F.; Cugnenc, P.; Thiounn, N.; Fridman, W.H.; Pagès, F. 2000: Interleukin-18: biological properties and clinical implications European Cytokine Network 11(1): 15-26
Men'shikov, V.V.; Orlov, V.A.; Beliakov, N.V. 1974: Prostaglandins and digestive organs (biochemistry, biological properties and clinical importance) Sovetskaia Meditsina 11: 68-72
Espada, J.; Brandan, N.C.; Dorado, M. 1973: Properties and characterization of human erythropoietin Acta Physiologica Latino Americana 23(6): 540-542
Słodkowska, J. 1989: Study of the relations between small cell lung cancer and the APUd system based on the analysis of clinical, biological and molecular-genetic properties Postepy Higieny i Medycyny Doswiadczalnej 43(5-6): 499-510
Mudrik, N.N.; Eshkind, L.G.; Manakova, T.E.; Karalova, E.M.; Abroian, D.O.; Tarantul, V.Z.; Gazarian, K.G. 1991: Biological effect of human erythropoietin in transgenic mice Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1991(10): 25-28
Hirata, T. 1976: Cell-biological study on the acid-fast organisms isolated and cultivated from leprosy patients. I. Isolation frequency and biological properties of the organisms REPURA. Leprosy 44(4): 214-220
Malavaud, B.; Game, X.; Villers, A.; Mouzin, M.; Mazerolles, C.; Rischmann, P.; Sarramon, J.P. 2001: Secondary biological recurrence after radical prostatectomy: multivariate analysis of prognostic clinical, biological, and histologic factors Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 11(2): 277-282
Heymer, B. 1975: Biological properties of the peptidoglycan Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 149(2-4): 245-257
Machnicki, M. 1991: Biological properties of lactotransferrin Folia Biologica 37(2): 65-76
Reinhart, W.H. 1994: Shear stress modulates erythropoietin secretion and explains unexpectedly low erythropoietin levels Journal of Laboratory and Clinical Medicine 123(6): 930-931
Damen, J.E.; Liu, L.; Wakao, H.; Miyajima, A.; Rosten, P.; Jefferson, A.B.; Majerus, P.W.; Krosl, J.; Humphries, R.K.; Krystal, G. 1997: The role of erythropoietin receptor tyrosine phosphorylation in erythropoietin-induced proliferation Leukemia 11(Suppl 3): 423-425
Schooley, J.C. 1980: Erythropoietin complexed with the F(ab')2 fragment of anti-erythropoietin retains its biologic activity Experimental Hematology 8(7): 830-836
Masuda, S.; Nagao, M.; Sasaki, R. 1999: Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production International Journal of Hematology 70(1): 1-6
Urra, J.M.; de la Torre, M.; Alcazar, R.; Peces, R. 1997: Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance Clinical Chemistry 43(5): 848-849
Pasha, Y.Z.; Ahmadpour-Kacho, M.; Hajiahmadi, M.; Hosseini, M.B. 2008: Enteral erythropoietin increases plasma erythropoietin level in preterm infants: a randomized controlled trial Indian Pediatrics 45(1): 25-28
Virón, B.éa.; Kolta, A.; Kiladjian, J.J.; Mignon, F.; Mayeux, P.; Casadevall, N. 2002: Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance Nephrologie 23(1): 19-22
Borota, R.; Borota, J.; Belić, A.; Gebauer, E.; Stefanović, N. 1996: Clinical use of erythropoietin Medicinski Pregled 49(9-10): 369-376
Royer, R. 1983: Synthesis and biological properties of 2-nitrobenzofurans Annales Pharmaceutiques Francaises 41(4): 299-311
Derendiaeva, T.N.; Kostiukova, N.N. 1980: Corynebacterium ulcerans and its biological properties Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 3-8